Objective: The testing of neonatal blood specimens dried on filter pap
er for maternal HIV antibodies, using an enzyme immunoassay (EIA) with
confirmation of repeatedly reactive specimens by immunoblot (IB), was
first described in 1987. It has been used to conduct large, unlinked,
anonymous HIV seroprevalence surveys for surveillance of HIV in child
-bearing women in several countries. We directly assessed the sensitiv
ity and specificity of this combination of tests to detect maternal HI
V antibodies. Setting: Serum samples obtained from mothers delivering
at a major hospital in Kinshasa, Zaire were screened for HIV antibody
using the rapid assay HIVCHEK. Design: Plasma from HIVCHEK-positive wo
men and age-matched negative controls were tested by enzyme-linked imm
unosorbent assay (ELISA); repeatedly reactive specimens were confirmed
by Western blot (WB). Two days after delivery, whole blood was obtain
ed from each newborn by heel-stick, dried on filter paper, and tested
by EIA. Repeatedly reactive specimens were confirmed by IB. Main outco
me measure. The serologic status of neonatal filter-paper specimens wa
s compared with that of corresponding maternal plasma. Results: The te
sting of neonatal filter-paper specimens using EIA, with confirmatory
testing of repeatedly reactive specimens using IB, was 100.0% sensitiv
e [of the 192 ELISA-positive and WB-positive maternal plasma specimens
, 192 of the corresponding newborn filter-paper specimens were EIA-pos
itive and IB-positive; 950/o confidence interval (CI), 98.1-100]. The
detection of maternal HIV antibodies was 99.60/o specific using this c
ombination of tests (of the 281 ELISA-negative or ELISA-positive but W
B-negative maternal plasma samples, 280 of the corresponding newborn f
ilter-paper specimens were EIA-negative or EIA-positive but IB-negativ
e; 950/o CI, 98.0-100). Conclusions: Maternal HIV antibodies can be de
tected accurately by testing neonatal blood dried on filter paper, usi
ng EIA with confirmation of repeatedly reactive specimens by IB. This
approach can facilitate the determination of HIV seroprevalence in chi
ld-bearing women in countries with neonatal screening programs, or whe
re serum or plasma is difficult to obtain.